131 related articles for article (PubMed ID: 2472321)
1. Bone marrow stromal culture from patients with myelodysplastic syndromes and patients at different stages of acute nonlymphocytic leukaemia.
Elstner E; Wächter M; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):167-74. PubMed ID: 2472321
[TBL] [Abstract][Full Text] [Related]
2. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
3. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
Gidáli J; Fehér I; Hollán SR
Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
7. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Peddie CM; Bowen DT; Pippard MJ
Leukemia; 2002 May; 16(5):785-90. PubMed ID: 11986938
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
9. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
10. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias.
Blazsek I; Farabos C; Quittet P; Labat ML; Bringuier AF; Triana BK; Machover D; Reynes M; Misset JL
Cancer Detect Prev; 1996; 20(1):31-42. PubMed ID: 8907201
[TBL] [Abstract][Full Text] [Related]
12. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
Murphy PB; Richman CM
Exp Hematol; 1989 Dec; 17(11):1105-9. PubMed ID: 2583254
[TBL] [Abstract][Full Text] [Related]
13. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
14. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
15. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
16. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
[TBL] [Abstract][Full Text] [Related]
17. Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome.
Narendran A; Hawkins LM; Ganjavi H; Vanek W; Gee MF; Barlow JW; Johnson G; Malkin D; Freedman MH
Pediatr Hematol Oncol; 2004; 21(3):209-21. PubMed ID: 15202160
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture.
Schölzel C; Löwenberg B
Exp Hematol; 1985 Aug; 13(7):664-9. PubMed ID: 3861327
[TBL] [Abstract][Full Text] [Related]
19. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
20. In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia.
Raymakers R; De Witte T; Joziasse J; Van der Lely N; Boezeman J; Haanen C
Br J Haematol; 1991 May; 78(1):35-41. PubMed ID: 2043479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]